HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lauré M Fijen Selected Research

Hereditary Angioedemas

3/2024Deucrictibant for angioedema due to acquired C1-inhibitor deficiency: A randomized-controlled trial.
2/2024CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.
11/2023Efficacy outcomes in trials with prophylactic hereditary angioedema therapy: A systematic review.
10/2023[Facial swelling due to angioedema: often mast cell mediated, but not always].
11/2022Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation.
1/2022Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review.
1/2022Inhibition of Prekallikrein for Hereditary Angioedema.
1/2022Prophylaxis with anti-activated factor XII for hereditary angioedema.
8/2021Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2.
1/2020Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lauré M Fijen Research Topics

Disease

10Hereditary Angioedemas
03/2024 - 01/2020
7Angioedema
03/2024 - 01/2020
1COVID-19
11/2021
1Hypertriglyceridemia
11/2021

Drug/Important Bio-Agent (IBA)

2PrekallikreinIBA
01/2022 - 01/2020
2BradykininIBA
08/2021 - 01/2020
1Bradykinin B2 ReceptorIBA
03/2024
1Kallikreins (Kallikrein)IBA
02/2024
1CRISPR-Associated Protein 9IBA
02/2024
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2023
1Histamine Antagonists (Antihistamines)IBA
10/2023
1Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
11/2022
1donidalorsenIBA
01/2022
1Factor XIIa (Coagulation Factor XIIa)IBA
01/2022
1Omalizumab (Xolair)FDA Link
01/2022
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
11/2021
1Plasma KallikreinIBA
08/2021
1KininsIBA
08/2021
1IONIS-PKK-LRxIBA
01/2020

Therapy/Procedure

5Therapeutics
03/2024 - 01/2022
1Subcutaneous Injections
01/2020